13F Holdings
中文EN

MDT Medtronic plc

Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 1613103 · Fiscal year ends 04/24

Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.8%
TTM net income YoY12.3%
TTM EPS YoY12.2%
Revenue 3-yr CAGR6.0%
Net income 3-yr CAGR13.1%

Margins

Gross margin65.0%
Operating margin18.1%
Net margin13.9%
FCF margin16.3%
EBITDA margin23.5%

Returns

ROE10.7%
ROA5.7%
ROIC (approx.)7.1%
Asset turnover0.41x

Leverage & solvency

Liabilities / assets45.5%
Debt / equity0.56x
Current ratio2.07x
Interest coverage9.37x

Cash quality & payout

Operating cash flow / net income1.54x
Accruals ratio-3.0%
Payout ratio69.8%
Capex / revenue5.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-04-24FY20252025-04-25FY20242024-04-26FY20232023-04-28FY20222022-04-29
Income statement
Revenue$36.36B$33.54B$32.36B$31.23B$31.69B
Cost of revenue$12.72B$11.63B$11.22B$10.72B$10.14B
Gross profit$23.64B$21.91B$21.15B$20.51B$21.54B
R&D expense$2.87B$2.73B$2.73B$2.70B$2.75B
SG&A expense$11.78B$10.85B$10.74B$10.41B$10.29B
Operating income$6.47B$5.96B$5.14B$5.49B$5.75B
Interest expense$715.00M$729.00M$719.00M$636.00M$553.00M
Pretax income$6.14B$5.63B$4.84B$5.36B$5.52B
Income tax$1.30B$936.00M$1.13B$1.58B$456.00M
Net income$4.80B$4.66B$3.68B$3.76B$5.04B
EBITDA$9.43B$8.82B$7.79B$8.18B$8.46B
EPS (basic)3.753.632.772.833.75
EPS (diluted)3.733.612.762.823.73
Dividends declared per share2.842.802.762.722.52
Weighted avg. shares (diluted)1.29B1.29B1.33B1.33B1.35B
Banking
Net interest income$383.00M$511.00M$597.00M$386.00M$186.00M
Balance sheet
Cash & equivalents$1.95B$2.22B$1.28B$1.54B$3.71B
Short-term investments$7.27B$6.75B$6.72B$6.42B$6.86B
Receivables$6.64B$6.51B$6.13B$6.00B$5.55B
Inventory$5.95B$5.48B$5.22B$5.29B$4.62B
Current assets$24.79B$23.81B$21.93B$21.68B$23.06B
PP&E, net$7.42B$6.84B$6.13B$5.57B$5.41B
Goodwill$42.59B$41.74B$40.99B$41.42B$40.50B
Intangibles$10.15B$11.67B$13.22B$14.84B$15.60B
Total assets$93.03B$91.68B$89.98B$90.95B$90.98B
Current liabilities$11.66B$12.88B$10.79B$9.05B$12.39B
Short-term debt$1.79B$2.87B$1.09B$20.00M$3.74B
Long-term debt$26.17B$25.64B$23.93B$24.34B$20.37B
Total debt$27.96B$28.52B$25.02B$24.36B$24.11B
Total liabilities$42.96B$43.42B$39.56B$39.28B$38.26B
Shareholders' equity$49.46B$48.02B$50.21B$51.48B$52.55B
Net debt$26.01B$26.30B$23.74B$22.82B$20.40B
Shares outstanding1.28B1.28B1.31B1.33B1.33B
Cash flow statement
Operating cash flow$7.33B$7.04B$6.79B$6.04B$7.35B
Capital expenditure$1.90B$1.86B$1.59B$1.46B$1.37B
Free cash flow$5.43B$5.18B$5.20B$4.58B$5.98B
Investing cash flow-$2.93B-$1.94B-$2.37B-$3.49B-$1.66B
Financing cash flow-$4.75B-$4.36B-$4.45B-$4.96B-$5.34B
Depreciation & amortization$2.96B$2.86B$2.65B$2.70B$2.71B
Stock-based compensation$457.00M$429.00M$393.00M$355.00M$359.00M
Dividends paid$3.64B$3.59B$3.67B$3.62B$3.38B
Share buybacks$1.03B$3.23B$2.14B$645.00M$2.54B

Free plan shows the latest 5 periods; Pro shows all 14 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.